$Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream$

Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream

Bibliographic Details
Main Authors:	Neda Shahriari, MD, Daniel R. Mazori, MD, Joseph F. Merola, MD, MMSc
Format:	Article
Language:	English
Published:	Elsevier 2023-02-01
Series:	JAAD Case Reports
Subjects:	IVIg JAK inhibition necrobiotic xanthogranuloma tofacitinib
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512622005410

Similar Items

Periorbital Necrobiotic Xanthogranuloma Successfully Treated with Intravenous Immunoglobulin
by: Rose M. Olson, et al.
Published: (2018-01-01)

PERIORBITAL NECROBIOTIC XANTHOGRANULOMA WITHOUT PARAPROTEINEMIA
by: Taeko Nakamura-Wakatsuki, et al.
Published: (2013-07-01)

Generalized Necrobiotic Xanthogranuloma in a Patient with Multiple Myeloma
by: María Jimenez, et al.
Published: (2014-12-01)

Necrobiotic xanthogranuloma with paraproteinemia without periorbital involvement—a case report
by: Chin-Yi Yang, et al.
Published: (2010-09-01)

Spectacular skin nodules: Cutaneous necrobiotic xanthogranuloma without paraproteinemia
by: Shimoni Kadakia, et al.
Published: (2012-01-01)

Necrobiotic xanthogranuloma with type 1 cryoglobulinemia mimicking necrobiosis lipoidica in a young woman with myeloma
by: Alexander Means, MD, et al.
Published: (2022-03-01)

A complex case of necrobiotic xanthogranuloma with IgG‐kappa paraproteinemia: Disease regression achieved with melphalan and prednisone combination therapy
by: Jacques A. J. Malherbe, et al.
Published: (2022-11-01)

Necrobiotic xanthogranuloma scleritis in a case of granulomatosis with polyangiitis (Wegener’s granulomatosis)
by: Keorochana N, et al.
Published: (2017-10-01)

Ulcerating necrobiotic xanthogranuloma: A clinical sign to reconsider progression from MGUS to multiple myeloma
by: Christopher J. Fay, BA, et al.
Published: (2023-10-01)

Primary Necrobiotic Xanthogranulomatous Sialadenitis with Submandibular Gland Localization without Skin Involvement
by: Myunghee Kang, et al.
Published: (2019-07-01)

An exuberant case of necrobiotic xanthogranuloma
by: Sofia Lopes, et al.
Published: (2020-01-01)

Necrobiotic Xanthogranuloma in a Patient with Multiple Myeloma
by: Marlies Wruhs, et al.
Published: (2016-12-01)

Tofacitinib
by: Nilgün Şentürk
Published: (2022-04-01)

Necrobiotic granuloma: An update
by: Achyut Pokharel, et al.
Published: (2018-01-01)

Ulcerating yellow plaques on the legs
by: Ashley DiLorenzo, MD, et al.
Published: (2021-08-01)

Acne exacerbation after tofacitinib treatment for alopecia areata
by: Sawsan Alharthi, et al.
Published: (2021-10-01)

Improvement of necrobiosis lipoidica with topical ruxolitinib cream after prior nonresponse to compounded topical tofacitinib cream
by: Shannon Nugent, BS, et al.
Published: (2022-11-01)

Tofacitinib for refractory ocular mucous membrane pemphigoid
by: Hayley James, et al.
Published: (2021-06-01)

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
by: Neda Shahriari, MD, et al.
Published: (2023-03-01)

Tofacitinib in Hypertrophic Lichen Planus
by: Peter Seiringer, et al.
Published: (2020-07-01)

Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021-10-01)

Tofacitinib in the treatment of refractory eczemas – a case series
by: Prasanna Duraisamy, et al.
Published: (2022-08-01)

NEW APPROACHES TO PHARMACOTHERAPY OF RHEUMATOID ARTHRITIS: TOFACITINIB
by: E. L. Nasonov
Published: (2014-06-01)

Tofacitinib for Prurigo Nodularis: A Case Report
by: Peng C, et al.
Published: (2022-03-01)

Periocular Necrobiotic Xanthogranuloma Successfully Treated with Intravenous Immunoglobulin
by: Judit Lukács, et al.
Published: (2017-03-01)

Treatment of cutaneous sarcoidosis with tofacitinib 2% ointment and extra virgin olive oil
by: Mariam Alam, MD, et al.
Published: (2021-03-01)

Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy
by: Katelyn Singh, BS, et al.
Published: (2021-01-01)

Tofacitinib for the Treatment of Steroid-Induced Rosacea
by: Li T, et al.
Published: (2022-11-01)

Relieving severe itching caused by scabies with tofacitinib: A case report
by: Zhenze Yu, et al.
Published: (2023-11-01)

Clinicopathological characteristics of 5 cases of adult orbital xanthogranulomatous disease
by: Ying Zhao, et al.
Published: (2022-01-01)

Efficacy and safety of tofacitinib for immune-mediated inflammatory rheumatic diseases (Part I)
by: E. L. Nasonov, et al.
Published: (2020-02-01)

Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report
by: Kai-Jun Zhu, et al.
Published: (2021-06-01)

Successful treatment of refractory IgA vasculitis with tofacitinib
by: Yi-Fei Xu, MD, et al.
Published: (2022-12-01)

Tofacitinib Blocks Entheseal Lymphocyte Activation and Modulates MSC Adipogenesis, but Does Not Directly Affect Chondro- and Osteogenesis
by: Tobias Russell, et al.
Published: (2021-12-01)

Dermoscopy could be useful in differentiating sarcoidosis from necrobiotic granulomas even after treatment with systemic steroids
by: Shahira Ramadan, et al.
Published: (2016-07-01)

Symmetrical Periorbital Yellow Plaques in a Patient with Haematological Dyscrasia: A Quiz
by: Emanuele Cozzani, et al.
Published: (2021-12-01)

Xanthogranuloma of the sellar region diagnosed by frozen section
by: Ji Kun, et al.
Published: (2016-01-01)

Two cases of bullous pemphigoid effectively treated with oral tofacitinib
by: Soundos Youssef, MD, et al.
Published: (2023-02-01)

Isolated giant xanthogranuloma of the orbit
by: Murthy Ramesh, et al.
Published: (2007-01-01)

Oral tofacitinib citrate for recalcitrant cutaneous lupus
by: Evelyne Bonnardeaux, MD, et al.
Published: (2022-02-01)